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COMMENTARY Open Access
Core outcome sets and systematic reviews
Mike Clarke1* and Paula R. Williamson2
Abstract
Systematic reviews seek to bring together research evidence to answer the question for the review. The reviewers
usually wish to compare, contrast and, if appropriate, combine the findings of the existing research studies. However,
these intentions are often thwarted by inconsistencies in the outcomes that were measured and reported in the
individual studies. This, in turn, makes it difficult for readers of the review to use it to make informed decisions
and choices about health and social care. One solution is for trials in a particular topic area to measure and report a
standardised set of outcomes, which would then be used in the review. Core outcome sets are a means of doing this,
providing an agreed standardised collection of outcomes for measuring and reporting for a specific area of health. In
this commentary, we argue for greater involvement of systematic reviewers in the development and implementation
of core outcome sets. This might help with, for example, the selection of outcomes to include in the Summary of
findings tables that provide users of the review with the key quantitative findings. Consideration of core outcome sets
when reviewers register their topics with Cochrane Review Groups or in PROSPERO would also help reviewers to plan
their reviews. A greater uptake of core outcome sets across research, including systematic reviews, would help towards
the ultimate aim of improving health and well-being through improving health and social care.
Background
Systematic reviews seek to bring together the evidence
from research that already exists, to answer the question
for the review. In many cases, the aim is to combine the
findings of the research studies in a meta-analysis,
thereby increasing statistical power and precision of the
effect estimate and supporting the conduct of additional
analysis, such as the investigation of the effects in differ-
ent subgroups. Even if there is no desire to combine the
results of the studies, reviewers might wish to compare
and contrast the included studies, to explore the effects
of clinical and methodological heterogeneity. However,
these intentions are often thwarted by inconsistencies in
the outcomes that were measured and reported in the
individual studies. It might not be possible to compare,
contrast or combine the results of the individual studies
because those results are presented for different out-
comes. This contributes to waste in research [1]. It
means that many reviews which would otherwise be able
to pool results and generate robust effect estimates are
unable to do much more than summarise the findings of
each of the eligible studies as a separate piece of infor-
mation. This, in turn, makes it difficult for readers to
use the review to make informed decisions and choices
about health and social care.
One solution, which would also help with streamlining
the systematic reviewing process [2], is for all trials in a
particular topic area to measure and report a standar-
dised set of outcomes and for these outcomes to be used
in the review. This would not limit the ability of re-
searchers to examine other outcomes that might be of
particular interest for their research but would mean
that every trial could contribute useful data to the ana-
lyses of the key outcomes. One means to achieve this is
through the development of core outcome sets, and we
present the case for greater involvement of the system-
atic review community in their development and imple-
mentation in this commentary. It builds on an earlier
commentary, encouraging greater use of core outcome
sets in trial registries [3].
Main text
Core outcome sets
Core outcome sets are an agreed standardised collection
of outcomes that should be measured and reported for a
specific area of health. These sets represent the minimum
that should be measured and reported in all clinical trials
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of a specific condition and are also suitable for use in
other types of research and clinical audit [4]. Although
there are examples of core outcome sets going back more
than 30 years [5], and some well-established ones such as
Outcome Measures in Rheumatology (OMERACT) for
rheumatoid arthritis [6], they are still relatively rare. A sys-
tematic review, with searches up to 2013, found just under
200 in the published literature, across a wide range of
areas but with many notable gaps, including for common
conditions such as diabetes [7]. In some areas of health
and social care, researchers might have already reached a
stage where all (or almost all) studies measure more or
less the same set of outcomes, but a formal process of
agreeing on a core outcome set might still help to cement
this informal consensus. This could also reinforce the im-
portant point that the standardisation which is achieved
with a core outcome set is not intended to stifle innovation
[4]. The outcomes in the set should represent the mini-
mum to be collected in all trials, and researchers should
continue to measure and report additional outcomes of
particular relevance to their topic. Likewise, systematic re-
viewers should continue to seek data on those outcomes
of particular relevance to their review, above and beyond
those in the core outcome set.
If core outcome sets are to contribute to improve-
ments in health and social care, by helping patients and
the public, practitioners and policy makers to make bet-
ter decisions about interventions, they need to contain
the outcomes that really matter to these stakeholders.
They need to be developed in a collaborative way, with
appropriate representation from key stakeholders, includ-
ing practitioners, patients and others users of health and
social care services; as well as researchers, policy makers
and those who fund services and research [3]. Systematic
reviewers from the relevant area of health or social care
should be among these stakeholders in the development
of core outcome sets. They may be able to help in relation
to the review of outcomes previously measured in studies
in the particular area and bring to the consensus process
the perspective of the researchers who might have strug-
gled most with inconsistencies in outcomes in the existing
literature. Their involvement may facilitate the incorpor-
ation of these views into the process and help to identify
ways to overcome some of the problems encountered by
reviewers when selecting outcomes for their reviews and
by users when reading reviews. Furthermore, explicit en-
gagement of systematic reviewers in the development of
core outcome sets may encourage subsequent uptake of
these sets by this group of researchers.
In order to facilitate the positive impact of core out-
comes sets on health and social care, the COMET (Core
Outcome Measures for Effectiveness Trials) Initiative
(www.comet-initiative.org) is seeking to support others in
the development and uptake of core outcome sets across
all areas of health and social care [8]. Since its launch in
2010, COMET has compiled resources to help people de-
veloping core outcome sets and a freely accessible data-
base of published core outcome studies, drawing on the
aforementioned systematic review [7] and subsequent up-
dating using the same search strategy [9]. Furthermore,
recognising the challenges that people reading reports of a
core outcome set face when trying to decide whether to
adopt an existing core outcome set or develop a new one,
work is underway to develop a reporting guideline, using
an international consensus process [10]. It is also import-
ant to note that the development of a core outcome set
which focuses on the what to measure may need to be
followed by decisions about how and when to measure.
Heterogeneity in how outcomes have been measured or
the timing of those measurements can undermine efforts
to facilitate the work of systematic reviewers who are trying
to compare, contrast and combine the results of multiple
studies even if the outcomes themselves are consistent
across the studies. This is an area of ongoing collaboration
between COMET and COSMIN (COnsensus-based Stan-
dards for the selection of health Measurement INstru-
ments) [11].
Core outcome sets in systematic reviews
Currently, the explicit use of core outcome sets in sys-
tematic reviews seems rare. For example, a survey of all
Cochrane Reviews that were first published in full in
2007 (387 reviews), 2011 (401), and 2013 (439) did not
identify any that cited a core outcome set as influencing
the choice of outcomes to investigate in the review but
found that these 1227 reviews included a total of nearly
9800 outcomes [12, 13]. Considering the new reviews
from 2013 only [13], the number of specified outcomes
in each review ranged from just one in three reviews to
62 in a review which examined different types of dietary
advice for women with gestational diabetes and specified
short- and long-term outcomes for both mother and child
[14]. The median number of outcomes was 7. The 439 re-
views specified a total of 3644 outcomes in their methods
sections. After excluding the 65 reviews that did not have
any included studies, 68 % (2134/3142) of these specified
outcomes were reported in the “Results” section of the re-
view. Of the 1008 non-reported outcomes across all re-
views that had studies in them, 77 % (775/1008) had not
been reported because they were not measured in the
studies included in the review or insufficient data were
available. No clear reason was found in the text of the re-
view for the non-reporting of the remaining 23 % (233/
1008) [13].
One of the ways in which core outcome sets might be
particularly useful for Cochrane Reviews [15] and other
systematic reviews is in the selection of outcomes to in-
clude in the Summary of findings tables developed by the
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Grading of Recommendations Assessment, Development
and Evaluation (GRADE) working group to summarise
the results for important outcomes and the quality of this
evidence [16]. For Cochrane Reviews, it is recommended
that these tables include seven or fewer outcomes, and
they have been shown to improve readers’ understanding
and speed of retrieval of the findings of the review [17].
They were introduced to Cochrane Reviews in 2008 and
were included in 112 (31 %) of the 361 full reviews
published for the first time in 2011 and containing at least
one included study, rising to 57 % (216 of 375 new reviews)
in 2013 [13].
Using core outcome sets when registering a systematic
review
An important opportunity for systematic reviewers to
make use of core outcome sets, and to be clear about
doing so, is when choosing the outcomes to assess in their
review. They can make this explicit in the protocol for
their review and in its prospective registration. Since its
inception, Cochrane has required authors of Cochrane Re-
views to have their proposed review approved by the rele-
vant Cochrane Review Group and then prepare and
publish the protocol for their review. Since 2011, it has
been possible for all systematic reviewers to register their
review at their outset in PROSPERO, a free-to-use registry
for systematic reviews developed and run by the Centre
for Reviews and Dissemination in the University of York,
UK [18]. PROSPERO recorded its 10,000th entry in 2015,
and as in the protocols for Cochrane Reviews, reviewers
are able to list the outcomes that they will attempt to as-
sess in the included studies in their registry entry. They
could mention their intended use of a core outcome set,
as we have suggested for trial registries such as Inter-
national Standard Randomised Controlled Trial Number
(ISRCTN) [3]. It would also allow the reviewers to specify
any additional outcomes that they are interested in. Speci-
fying the outcomes from the core outcome set, and using
the terms for these outcomes that were used in that core
outcome set, would facilitate searching of PROSPERO and
the protocols for Cochrane Reviews. Another benefit from
considering the core outcome set in the design and regis-
tration of their review is that this might help reviewers to
choose the outcomes to include in a Summary of findings
table. This might also help to focus their subsequent ac-
tions, including the seeking of data that are not available
in the reports of eligible studies so that they obtain infor-
mation that is as complete as possible for these outcomes.
When others inspect the registry entry for a review, the
explicit use of a core outcome set will help them to decide
if the eventual review is affected by selective reporting bias
because the review authors have not included all the out-
comes from the core outcome set when presenting their
results [19].
Conclusion
Systematic reviewers are often the researchers who strug-
gle most because of inconsistencies in the outcomes that
have been measured and reported in trials of health and
social care. This hampers their ability to resolve the uncer-
tainties that they seek to address in their reviews. They
can help to overcome these problems by becoming in-
volved in the development of core outcome sets and then
using them as a foundation for the outcomes to include in
their review and summaries, such as the Summary of find-
ings tables [14]. We welcome comments on these sugges-
tions and those that we made earlier for trial registries [3],
with the overall intention of helping reviewers and other
researchers achieve their ultimate aim of improving health
and well-being through improving health and social care.
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